A study investigating T cell activation and function by analyzing T cell secreted cytokines in patients with advanced melanoma treated with ipilimumab
Latest Information Update: 29 Jul 2016
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Pharmacodynamics
- 29 Jul 2016 New trial record
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.